TECNIS Synergy™ Toric II OptiBlue® PC-IOL (Intraocular Lens), is intended to provide high-quality, continuous vision over a full range of distances, including far, intermediate and near, to increase spectacle independence. These T oric IOLs compensate for corneal spherical aberration and corneal astigmatism. 1

NEW DELHI , Dec. 28, 2022 /PRNewswire/ —  Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced the particular availability associated with TECNIS Synergy™ Toric II OptiBlue ® PC-IOL for patients with astigmatism in India . TECNIS Synergy™ Toric II IOL, is a continuous-range-of-vision lens engineered for rotational stability, which locks in visual performance and provides high-quality vision 1 .

Cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, with more than 90% of people developing cataracts by the particular age of 65. 2, 3 Most people will develop cataracts at some point in their life, and modern cataract surgery is a safe and effective treatment that has a success rate of nearly 98%. 4 In India , nearly 73% of adults 60 years and older have cataracts 5 and if left untreated, cause vision to deteriorate more than time. Astigmatism reduces distance and close to visual acuity, vision quality, and depth perception. 6, 7 All cataracts will eventually need in order to be surgically removed plus replaced with an artificial lens, called an IOL (Intraocular lens).

Burzin Shahana , Country Manager at Johnson & Manley Vision, Surgical Vision Indian, said, “At Johnson & Johnson Vision, we are deeply engaged along with Indian health care professionals to reduce cataract burden through innovative, quality-based technologies and products. TECNIS Synergy™ Toric II OptiBlue ® PC-IOL is an advanced IOL solution for cataract patients with astigmatism and gives patients the visible clarity plus increased vision independence to improve their current lifestyles. ” He also added, “The launch will also expand available options physicians have to provide value to their patients along with astigmatism. inch

New TECNIS Synergy™ Toric II OptiBlue ® PC-IOL (Intraocular Lens) offers an opportunity to address both presbyopia and astigmatism at the time of cataract surgery. 8 It’s designed to:

  • Provide high-quality, constant vision over a full range of distances, including far, intermediate plus near, to increase spectacle independence. These types of T oric IOLs compensate with regard to corneal spherical aberration and corneal astigmatism. 1
  • The posterior optic of the zoom lens has the proprietary diffractive surface designed to correct chromatic incongruité for enhanced contrast sensitivity and offer high-quality vision over a full range associated with distances. The diffractive design of this lens leads in order to high visual acuities across all ranges and a continuous range of eyesight from much through near, resulting in increased spectacle independence. one
  • New frosted haptic design increases the amount of friction between the lens haptic surface plus the capsular bag to lock in the Intraocular Lens regarding rotational balance and visible performance.

In Of india , TECNIS Synergy™ Toric II OptiBlue ® PC-IOL has been approved by the particular Central Drugs Standard Control Organisation (CDSCO).

About Johnson & Manley Vision*

At Johnson & Manley Vision, part of Johnson & Johnson Healthcare Devices Companies, we have a bold ambition: in order to change the trajectory of eye wellness worldwide. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes intended for patients throughout their lives, with products and technologies that will address unmet needs which includes refractive error, cataracts, and dry vision. In communities with greatest need, all of us work in collaboration to expand access to high quality eye treatment, and we are committed to helping people see much better, connect better, live much better.

About Johnson & Manley Medical Devices Companies**

At Johnson & Manley Medical Products Companies, we have been helping individuals live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, plus take bold steps that lead in order to new standards of care while improving people’s health care experiences. Within surgery, orthopaedics, vision, and interventional solutions, our company is helping to save lives plus paving the way to a healthier future for everyone, everywhere.

*Johnson & Johnson Vision represents the items and services of Manley & Johnson Surgical Eyesight, Inc., Manley & Johnson Vision Care, Inc., and the affiliates of each.  
**The Manley & Johnson Medical Gadgets Companies comprise the surgical treatment, orthopedics, vision, and interventional solutions businesses within Manley & Johnson’s Medical Devices segment.

1 TECNIS Synergy™ Toric II OptiBlue ® IOL Pack Insert   
2 World Health Organization. Blindness plus Impairment. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment    
3 Kellogg Eye Center. Cataract. www.umkelloggeye.org/conditions-treatments/cataract      
4 Vision Health Initiative, Common Eye Disorders. Centers to get Disease Manage and Prevention.   https://www.cdc.gov/visionhealth/basics/ced/index.html    
five Vashist P, Talwar B, Gogoi M, Maraini G, Camparini M, Ravindran RD, Murthy GV, Fitzpatrick KE, John N, Chakravarthy U, Ravilla TD, Fletcher AE. Prevalence associated with cataract in an older population inside India : the India study of age-related attention disease. Ophthalmology. 2011 Feb; 118(2): 272-8. e1-2.    
6 Wolffsohn JS, Bhogal Gary the gadget guy, Shah S (2011) Effect of uncorrected astigmatism on vision. J Cataract Refract Surg 37 (3): 454-460. 7 Read SA, Vincent SJ, Collins MJ (2014) The visual and functional impacts associated with astigmatism and its clinical management. Ophthalmic Physiol Opt 34 (3): 267-294.
7 eight   https://www.beyondcataracts.com/cataract-treatment/tecnis-synergy-iols – accessed on 4th Nov’22 PP2022CT5406

SOURCE Johnson & Manley Medical Products Companies

Leave a Reply

Your email address will not be published. Required fields are marked *